Publication | Open Access
The Rationale and Design of the Reducing Pathology in Alzheimer’s Disease through Angiotensin TaRgeting (RADAR) Trial
35
Citations
61
References
2017
Year
This study will identify whether losartan is efficacious in the treatment of AD and whether definitive Phase III trials are warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1